VRN 10
Alternative Names: VRN-10Latest Information Update: 08 Feb 2023
At a glance
- Originator Voronoi
- Class Antineoplastics; Small molecules
- Mechanism of Action ERBB 2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical HER2 positive breast cancer